SCHEMBL3149298

SCHEMBL3149298

Nc1ccc(Cc2c[nH]cn2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ CYP3A4 P08684 3/20 0.48
▸ ALDH1A1 P00352 2/20 0.48
▸ TSHR P16473 1/20 0.48
▸ TDP1 Q9NUW8 1/20 0.48
▸ HRH3 Q9Y5N1 1/20 0.44
▸ CYP17A1 P05093 1/20 0.40
▸ CYP19A1 P11511 1/20 0.40
▸ CYP11B1 P15538 1/20 0.40
▸ CYP11B2 P19099 1/20 0.40
▸ GFER P55789 1/20 0.38
▸ HTR6 P50406 1/20 0.38
▸ LOXL2 Q9Y4K0 1/20 0.37
▸ HSP90AB1 P08238 1/20 0.36
▸ NPC1 O15118 2/20 0.34
▸ RAB9A P51151 2/20 0.34
▸ HTT P42858 1/20 0.34
▸ RAD52 P43351 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6971279 0.85 HRH3 (0.38) L3MBTL1HRH3LOXL2HSP90AB1
SCHEMBL3151668 0.83 GFER (0.52) L3MBTL1CYP3A4ALDH1A1TSHRTDP1
SCHEMBL11047959 0.81 HSP90AB1 (0.47) ALDH1A1HSP90AB1LMNAGAA
SCHEMBL28260270 0.81 HTR2C (0.40) ALDH1A1LOXL2LMNAMAPTGAA
SCHEMBL11050091 0.81 LPL (0.36) ALDH1A1HRH3NPC1RAB9ALMNA
SCHEMBL6972732 0.81 NOTUM (0.39) ALDH1A1NPC1RAB9AHTTCYP1A2
SCHEMBL28216766 0.81 ESR1 (0.48) CA2
SCHEMBL649075 0.80 ALDH1A1 (0.46) L3MBTL1ALDH1A1TSHRTDP1HRH3
Immethridine SCHEMBL845141 0.78 HRH4 (0.44) CYP3A4ALDH1A1HRH3CYP17A1CYP19A1
SCHEMBL6966762 0.78 PRSS1 (0.46) LOXL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2157081-A1 Indolinones substituted in six locations, their manufacture and their application as medicine Boehringer Ingelheim Pharma GmbH & Co. KG (DE) 2010-02-24 — — EP disclosed
US-6762180-B1 Substituted indolines which inhibit receptor tyrosine kinases BOEHRINGER INGELHEIM PHARMA KG (DE) 2004-07-13 — — US disclosed
EP-1224170-A1 6-POSITION SUBSTITUTED INDOLINE, PRODUCTION AND USE THEREOF AS A MEDICAMENT Boehringer Ingelheim Pharma KG (DE) 2002-07-24 — — EP disclosed
US-6407132-B1 ANTIHISTAMINES, ANTIALLERGENS, ANTIASTHMATICS, ANTICONVULSANTS, AND ANTIDEPRESSANTS; SKIN RASH TREATMENT JAMES BLACK FOUNDATION LIMITED (GB) 2002-06-18 — — US disclosed
WO-2001027081-A1 6-POSITION SUBSTITUTED INDOLINE, PRODUCTION AND USE THEREOF AS A MEDICAMENT BOEHRINGER INGELHEIM PHARMA KG (DE) 2001-04-19 — — WO disclosed
US-6043254-A ANTIPROLIFERATIVE AGENT; ENZYME INHIBITOR BOEHRINGER INGELHEIM PHARMA KG (DE) 2000-03-28 — — US disclosed
WO-1999005115-A1 SUBSTITUTED IMIDAZOLE DERIVATIVES AND THEIR USE AS HISTAMINE H3 RECEPTOR LIGANDS JAMES BLACK FOUNDATION LIMITED (GB) 1999-02-04 — — WO disclosed
Send feedback